Yatırımcı.AI

AKSA vs ONCSM Comparison

Price, market cap, valuation, profitability and leverage metrics of AKSA and ONCSM side by side.

AKSAONCSM
StockFund

If You Had Invested TRY 10,000

Metric Comparison

AKSA vs ONCSM Comparison
MetricAKSAONCSMSector median
Last price (TL)9.9682.9010.81
Daily change−0.30%−1.25%−0.30%
Market capTRY 38.7BTRY 2BTRY 2.9B
P/E5.9725.1611.94
P/B1.063.960.80
Dividend yield5.23%—1.06%
Return on equity19.47%18.26%1.14%
Free float29.13%42.28%36.14%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the AKSA vs ONCSM Comparison

Price, market cap, valuation multiples, profitability and leverage of AKSA (Aksa) and ONCSM (Oncosem Onkolojik Sistemler) side by side as of Nov 2, 2026, 16:42. Of the 16 metrics compared, AKSA leads in 7 and ONCSM leads in 9.

Highlights: Daily change: AKSA leads (−0.30% vs −1.25%). Market cap: AKSA leads (TRY 38.7B vs TRY 2B). P/E: AKSA leads (5.97 vs 25.16). P/B: AKSA leads (1.06 vs 3.96). EV/EBITDA: ONCSM leads (7.10 vs 8.75). EV/Sales: AKSA leads (2.73 vs 4.50). Gross margin: ONCSM leads (54.30% vs 14.83%). EBITDA margin (annual): ONCSM leads (41.91% vs 21.09%).

Frequently Asked Questions

By P/E, AKSA is cheaper (5.97 vs 25.16); by P/B, AKSA trades at the lower multiple (1.06 vs 3.96).

Annual net margin is 17.92% for AKSA and 10.83% for ONCSM; return on equity is 19.47% for AKSA and 18.26% for ONCSM.

The leverage ratio is 51.59 for AKSA and 44.59 for ONCSM; net debt/EBITDA is 3.02 for AKSA and 0.48 for ONCSM. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.